Research and Markets: Living with Depression: In-Depth Analysis of a Large Study of 2,000+ Patients with Varying Levels of Depression in the UK, Germany and US

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/da75ba/living_with_depres) has announced the addition of the "Living with Depression" report to their offering.

In-depth analysis of a large online study amongst over 2,000 patients with varying levels of depression in the UK, Germany and US, unveiling patients' attitudes, feelings, treatment programmes and needs for coping with life with diabetes, including an actionable segmentation for communicating with them.

Depression affects approximately 121 million people worldwide, and the World Health Organisation predicts that by 2020 the condition will be the second leading contributor to the global burden of disease.

Living with Depression' is an insightful study which forms part of an ongoing series of topical, research based market reports.

Pharma brands need access to unique insight if they are to develop effective products and treatments and relevant communications messages. To this end, this latest study has been designed to provide an in-depth analysis of the depression market across Europe and the US, unveiling patient attitudes, needs and treatment programmes.

A snapshot view of the data:

• 44% of the patients surveyed state their current episode has lasted more than 5 years, suggesting they do not consider their depression to be episodic
• Overall, patients waited an average of more than two years (27 months) after they started to feel depressed before visiting a doctor
• Over half (58%) of the patients surveyed have a family member also suffering from depression

Order this insightful report to receive an in-depth understanding of:

• Life with depression from the patients' perspective
• How demographics and patient profile impacts attitudes and behaviours
• The experiences and perceptions that ultimately define treatment decisions
• The filters patients apply to drug decisions

Use this strategic information to:

• Understand what really drives patient behaviour
• Improve patient compliance and health
• Develop products which are tailored to patient needs
• Deliver communications messages which will effectively resonate with patients

Methodology

30 minute online interviews amongst a broad sample of patients ranging from the mildly depressed to the severely depressed.

Deliverables

A comprehensive PowerPoint report, containing information pertaining to:

Attitudes to depression and the impact of depression on patients' lives:

• Do patients feel there is a stigma attached to the diagnosis of depression?
• How much control do patients feel they have over the causes of their depression?
• Do patients feel supported by their families and peers?

Attitudes to interaction with physicians/therapists:

• Do patients feel supported by healthcare professionals?
• To what extent do patients adhere to keeping appointments?
• Why do they miss appointments?

Attitudes towards treatments received, encompassing prescription medication, over-the-counter remedies as well as therapy:

• Who are the patients who are resistant to treatment?
• Are they defined purely by severity of disease and treatment history?
• Do attitudinal factors play a role?

Products mentioned: Celexa, Cipramil, Prozac, Fluctine, Zoloft, Lustral, Effexor, Trevilor, Venlalic, Wellbutrin, Zyban, Paxil, Seroxat, Pexeva, Lexapro, Cipralex, Cymbalta, Yentreve, Elavil, Amineurin, Endep

Key Topics Covered:

Section 1: Sociodemographics & Background on depression

• Global findings
• Country-specific findings

Section 2: Living with depression

• Global findings
• Country-specific findings

Section 3: Treatment of depression

• Global findings
• Country-specific findings

Section 4: Patient segmentation

The report can also be purchased on an individual country basis. Please visit the link below for further details.

http://www.researchandmarkets.com/research/da75ba/living_with_depres